-SEC Filing
CorMedix Inc. Announces Notice Of Allowance For U.S. Patent Application Covering Lead Product DefenCath
CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that